Navigation Links
Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS
Date:5/14/2009

- Phase 3 CAPACITY results poster presentation Sunday, May 17, 8:15 a.m. PDT -

- Phase 3 CAPACITY results oral presentation, Tuesday, May 19, 3:35 p.m. PDT -

- Conference call and webcast Tuesday, May 19, 6 p.m. PDT -

BRISBANE, Calif., May 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that an oral late-breaker presentation and two poster discussion presentations related to the company's pulmonology programs will be presented at the 2009 International Conference of the American Thoracic Society (ATS) in San Diego. In addition, the company will conduct a conference call and webcast to discuss the results of its Phase 3 CAPACITY program on Tuesday, May 19 at 6:00 p.m. PDT (9:00 p.m. EDT).

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "We are very pleased that our Phase 3 CAPACITY program will be the subject of two significant sessions at this year's ATS meeting. Details of the CAPACITY results will be presented in a poster discussion session on the morning of Sunday, May 17. A more in-depth presentation of the efficacy and safety data from the two CAPACITY studies will be the subject of an oral late-breaker presentation on Tuesday, May 19. In addition, the results of a large study examining the predictors of mortality in patients with idiopathic pulmonary fibrosis (IPF) will be presented in a poster discussion session on Sunday, May 17. Among the independent predictors of mortality identified in the study was change in percent predicted forced vital capacity (FVC), the primary endpoint and a component of important secondary endpoints in our CAPACITY program."

The schedule of presentations at ATS related to InterMune's efforts in the research and development of new medicines for IPF are as follows:
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Oncothyreon reports first quarter 2009 financial results
2. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
3. Transgenomic, Inc. Reports First Quarter 2009 Results
4. Insmed Announces First Quarter 2009 Financial Results
5. BioMS Medical Announces First quarter 2009 results
6. Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
7. China Sky One Medical, Inc. Schedules Conference Call to Discuss First Quarter 2009 Results
8. deCODE genetics Announces First Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
10. Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
11. VIVUS Reports First Quarter 2009 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... Houston, Texas (PRWEB) April 23, 2015 ... patient’s True Flow (blood flow through the device) in ... provided by Numerex, the world’s leading provider of Machine ... IoT. , True Flow via VADLink.com ... if there is any drop in flow below a ...
(Date:4/22/2015)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the first quarter ended March 31, 2015, ... or $0.08 per share, compared to a net loss ... same period in 2014. As of March 31, 2015, ... interest receivable of $226.1 million. Revenues for ...
(Date:4/22/2015)... 22, 2015 Today, DuPont announced ... a leading microbiome discovery company. This acquisition will ... access in both seed and crop protection to ... globally. , “In 2014, the businesses in ... segments sold more than $1 billion in biological ...
(Date:4/22/2015)... Over the last five years, ... growth primarily due to growth in the ... increased nanotechnology R&D expenditure and increased international ... http://www.marketsandmarkets.com/requestCustomization.asp?id=65048077 , In this report, the ... on the basis of products and applications. ...
Breaking Biology Technology:Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8DuPont Acquires Taxon Biosciences, Inc. 2DuPont Acquires Taxon Biosciences, Inc. 3DuPont Acquires Taxon Biosciences, Inc. 4Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 2Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 3
... API Software, Inc. announced today ... implement the majority of APIs suite of labor ... The solution will include Payrollmation time and attendance, ... human resources software. , ,The hospital is adopting ...
... Network Health Plan , Affinity Health Systems health plan ... today the availability of new online services for NHPs ... Internet-based health management system. , ,NHP will launch the ... member portals. Starting this summer, NHPs providers will be ...
... swing a golf club with one arm, or to write a ... would you? Or, at the very least, progress would be painfully ... human embryonic stem cells, the bodys core cells that can grow ... of embryonic stem cell research have turned out to be much ...
Cached Biology Technology:Lifting federal limits on stem cell research would speed search for cures 2Lifting federal limits on stem cell research would speed search for cures 3
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... a landscape susceptible to invasion by alien plant species, ... contributing to the accelerating spread of exotic aquatic species, ... issue of BioScience. John A. Havel of Southwest Missouri ... Vander Zanden of the University of Wisconsin survey evidence ...
... multiple complex biological interactions in a yeast cell in ... the networks of interaction by which components of a ... Open Access journal Journal of Biology shows that such ... predictions about interactions that haven't been observed experimentally. , ...
... just can't tell where you might find love these ... and a social psychologist found love-related neurophysiological systems inside ... responses in the brains of 17 young men and ... madly in love. , The multidisciplinary team found that ...
Cached Biology News:Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Navigating an integrated yeast network 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 3Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 4Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 5Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 6
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
Biology Products: